Antibody Drug Conjugate: The new science

6, Jan 2022 External Event

Date: 12 May 2022

Venue: Virtual event

Organised by: Joint Pharmaceutical Analysis Group

Overview: Antibody drug conjugates (ADCs) are an exciting and challenging new area of research and are becoming ever more popular across the industry with more than 100 ADCs reported in the clinic. The targeted nature of the molecules makes them extremely suitable for delivering toxic molecules to the biological target. However, the complexity of the molecules and the lack of regulatory experience increases the complexity in discovery and development across all disciplines. This symposium brings together experts from across the industry to share their knowledge and learning for an engaging and exciting meeting.

Event link: